Open Questions: Experiments

Ranked research questions extracted from wiki pages and knowledge gaps
Field: GenesProteinsMechanismsTherapeuticsDiseasesPathwaysCell TypesBrain RegionsMethods
Sort by: Importance Elo Potential Impact Tractability
47 questions found for field 'Experiments'
open ⚖ 1500
BBB crossing**: How do autoantibodies cross the blood-brain barrier?
📑 0.50 💥 0.50
open ⚖ 1500
PD Cure Roadmap Gap #11** (28 pts): Can we develop reliable prodromal biomarkers?
📑 0.50 💥 0.50
open ⚖ 1500
PD Cure Roadmap Gap #4** (30 pts): What is the role of the gut-brain axis in PD pathogenesis?
📑 0.50 💥 0.50
open ⚖ 1500
Combination Therapy
📑 0.50 💥 0.50
open ⚖ 1500
Improved Delivery
📑 0.50 💥 0.50
open ⚖ 1500
Biomarker Integration
📑 0.50 💥 0.50
open ⚖ 1500
Gap #12**: What is the relationship between striatal alpha-synuclein and treatment response?
📑 0.50 💥 0.50
open ⚖ 1500
Early biomarker identification
📑 0.50 💥 0.50
open ⚖ 1500
Therapeutic development
📑 0.50 💥 0.50
open ⚖ 1500
Disease modification
📑 0.50 💥 0.50
open ⚖ 1500
Personalized medicine
📑 0.50 💥 0.50
open ⚖ 1500
Expanded enrollment
📑 0.50 💥 0.50
open ⚖ 1500
Combination therapy
📑 0.50 💥 0.50
open ⚖ 1500
Biomarker development
📑 0.50 💥 0.50
open ⚖ 1500
Regulatory engagement
📑 0.50 💥 0.50
open ⚖ 1500
Autoantibody origin
📑 0.50 💥 0.50
open ⚖ 1500
T-cell specificity
📑 0.50 💥 0.50
open ⚖ 1500
BBB crossing
📑 0.50 💥 0.50
open ⚖ 1500
Microglial interactions
📑 0.50 💥 0.50
open ⚖ 1500
Parkinson's disease
📑 0.50 💥 0.50
open ⚖ 1500
Amyotrophic lateral sclerosis
📑 0.50 💥 0.50
open ⚖ 1500
Multiple sclerosis
📑 0.50 💥 0.50
open ⚖ 1500
Frontotemporal dementia
📑 0.50 💥 0.50
open ⚖ 1500
Gene Therapy
📑 0.50 💥 0.50
open ⚖ 1500
Therapeutic screening
📑 0.50 💥 0.50
open ⚖ 1500
Gene therapy
📑 0.50 💥 0.50
open ⚖ 1500
Biomarker development
📑 0.50 💥 0.50
open ⚖ 1500
Combination therapies
📑 0.50 💥 0.50
open ⚖ 1500
Dose-response relationships**: What acceleration thresholds trigger specific pathological stages?
📑 0.50 💥 0.50
open ⚖ 1500
Impact location mapping**: Which brain regions are most vulnerable to specific impact types?
📑 0.50 💥 0.50
open ⚖ 1500
Clinical phenotype determinants**: Why do some athletes develop behavioral variant CTE (impulsivity, aggression) while others develop cognitive variant (memory loss, executive dysfunction)?
📑 0.50 💥 0.50
open ⚖ 1500
Individual susceptibility modifiers**: Why do some athletes with extensive exposure never develop CTE?
📑 0.50 💥 0.50
open ⚖ 1500
PD Cure Roadmap Gap #3** (30 pts): Why do some LRRK2/GBA mutation carriers never develop PD?
📑 0.50 💥 0.50
open ⚖ 1500
Autoantibody origin**: Where and how do neural antigen autoantibodies develop?
📑 0.50 💥 0.50
open ⚖ 1500
T-cell specificity**: What are the antigen-specific T-cell responses in AD?
📑 0.50 💥 0.50
open ⚖ 1500
Microglial interactions**: How do autoantibodies interact with resident immune cells?
📑 0.50 💥 0.50
open ⚖ 1500
PD Cure Roadmap Gap #1** (40 pts): Can neurotrophin signaling be restored to prevent dopaminergic neuron loss?
📑 0.50 💥 0.50
open ⚖ 1500
PD Cure Roadmap Gap #10** (28 pts): What are the mechanisms of non-motor symptom progression?
📑 0.50 💥 0.50
open ⚖ 1500
Multicenter trials
📑 0.50 💥 0.50
open ⚖ 1500
Biomarker development
📑 0.50 💥 0.50
open ⚖ 1500
Gene therapy
📑 0.50 💥 0.50
open ⚖ 1500
Device development
📑 0.50 💥 0.50
open ⚖ 1500
M1 muscarinic agonists
📑 0.50 💥 0.50
open ⚖ 1500
Nicotinic modulators
📑 0.50 💥 0.50
open ⚖ 1500
5-HT6 antagonists
📑 0.50 💥 0.50
open ⚖ 1500
Norepinephrine modulators
📑 0.50 💥 0.50
open ⚖ 1500
Deep brain stimulation
📑 0.50 💥 0.50

🌱 Cross-Pollination

Fields that illuminate Experiments through bridging wiki connections. See all cross-field connections →

Cross-pollination from Genes 1,139 bridges →
Cross-pollination from Biomarkers 2,281 bridges →
Cross-pollination from Cell 44 bridges →
Open Questions | Part of the SciDEX Atlas layer | API | Cross-field map